Tetra Med Sciences begins operations at R&D centre in HyderabadIllustrative image – not actual.
Tetra Med Sciences, a subsidiary of Tetra Global in St Louis, US, kicked off their research and development (R&D) centre operations at Hyderabad, Telangana. 
 
The company is engaged in the new molecule development and building a portfolio of molecules required in coming five to 10 years. 
 
The initial focus will be on developing molecules with their intermediates for APIs and going off-patent now and in coming five to 10 years; and after getting drug license, work on finished API doses also. 
 
The company aims to work on API and other domains; and plans to acquire their own production facility centre at the earliest, but for now has signed a third party facility for immediate needs. 
 
The company is currently working on molecules for pharma and plans to roll out cost competent and non-infringing intermediates. The team has expertise in the fields of drug discovery, medicinal chemistry, besides aroma chemicals.
← All latest storiesBack to top →